Mitochondrial-derived peptide for metabolic and exercise-adaptation support.
MOTS-C is a mitochondrial-encoded peptide implicated in metabolic homeostasis and exercise capacity. Emerging longevity applications target insulin sensitivity and aging biology.
Subcutaneous injection 2–3× weekly for 8–12 week cycles.
Mitochondrial-derived peptide activating AMPK; enhances glucose uptake and fatty-acid oxidation.
Well tolerated in reported protocols. Not FDA approved.
This page is educational and not medical advice. All VitaFlow protocols require evaluation by a licensed Florida physician.
Different mechanism — AMPK activation vs GLP-1.
8–12 weeks.
Only with physician supervision.
HbA1c, fasting insulin.
GHRH analog that stimulates your body's own growth hormone in a physiologic pattern.
Long-acting GHRH analog often paired with Ipamorelin for GH optimization.
Selective GH secretagogue with minimal impact on cortisol, prolactin or appetite.
Meet with a VitaFlow physician to design a protocol tailored to your goals, biomarkers, and lifestyle.
